Heidelberg, Germany

Alexander Duwe

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mtm Laboratories, Ag. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Duwe. Retrieved from https://idiyas.com/inventor/alexander-duwe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Biography of Inventor Alexander Duwe

Introduction: Alexander Duwe is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of neoplastic disorders.

Latest Patents: Alexander Duwe holds a patent for a method for detecting neoplastic disorders in a solubilized body sample. This invention focuses on the early diagnosis of various cancers, including those of the respiratory tract, urinary system, reproductive tract, and cancers associated with HPV infection. The patent also encompasses the development of test kits and in-vitro diagnostic devices for these purposes.

Career Highlights: Alexander Duwe has been instrumental in advancing diagnostic methods that can lead to earlier and more accurate cancer detection. His work has the potential to improve patient outcomes significantly.

Collaborations: Throughout his career, Alexander has collaborated with esteemed colleagues such as Ruediger Ridder and Anja Reichert. These collaborations have further enhanced the impact of his innovations in the medical field.

Conclusion: Alexander Duwe's contributions to medical diagnostics exemplify the importance of innovation in healthcare. His work continues to pave the way for advancements in the early detection of cancer, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…